Literature DB >> 31399938

Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients.

Pamela M Rist1, Julie E Buring2, Kathryn M Rexrode3, Nancy R Cook2, Natalia S Rost4.   

Abstract

Most studies of white matter hyperintensity volume (WMHV) in stroke patients lack reliable information on antecedent exposure to vascular risk factors. By leveraging prospective cohort data, we explored associations between lifestyle and health factors assessed 1 year prior to stroke and WMHV in individuals who experienced an ischemic stroke. This analysis was nested within two large prospective studies of initially healthy individuals. Information on lifestyle factors and health conditions was collected prior to the stroke event through annual or biannual questionnaires. For individuals who experienced their first confirmed ischemic stroke and had available magnetic resonance imaging, we measured WMHV using a validated semiautomated method. Linear regression was used to explore associations between lifestyle factors and health conditions and log-transformed WMHV. We measured WMHV in 345 participants with a first ischemic stroke event (mean age = 74.4 years; 24.9% male). After multivariate adjustment, history of diabetes was associated with decreased WMHV (p value = 0.06) while history of transient ischemic attack (p value = 0.09) and hypertension (p value = 0.07) were associated with increased WMHV. Most lifestyle factors and health conditions measured 1 year prior to stroke were not associated with WMHV measured at the time of ischemic stroke. Future studies could examine whether long term exposure to these factors impacts diffuse microvascular ischemic brain injury among stroke patients.

Entities:  

Keywords:  Risk factors; Stroke; White matter hyperintensities

Mesh:

Year:  2019        PMID: 31399938      PMCID: PMC6842429          DOI: 10.1007/s10654-019-00546-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  25 in total

1.  Neuropathologic correlates of white matter hyperintensities.

Authors:  Vanessa G Young; Glenda M Halliday; Jillian J Kril
Journal:  Neurology       Date:  2008-08-06       Impact factor: 9.910

2.  Setting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study.

Authors:  Natalia S Rost; Saloomeh Sadaghiani; Alessandro Biffi; Kaitlin M Fitzpatrick; Lisa Cloonan; Jonathan Rosand; Dean K Shibata; Thomas H Mosley
Journal:  J Neurosci Methods       Date:  2014-01-15       Impact factor: 2.390

3.  Determinants of white matter hyperintensity volume in patients with acute ischemic stroke.

Authors:  Natalia S Rost; Rosanna Rahman; Shruti Sonni; Allison Kanakis; Christi Butler; Efi Massasa; Lisa Cloonan; Aaron Gilson; Pilar Delgado; Yuchiao Chang; Alessandro Biffi; Jordi Jimenez-Conde; Angela Besanger; Gisele Silva; Eric E Smith; Jonathan Rosand; Karen L Furie
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-05       Impact factor: 2.136

4.  Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study.

Authors:  D Liao; L Cooper; J Cai; J F Toole; N R Bryan; R G Hutchinson; H A Tyroler
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

5.  Validation of intracranial area as a surrogate measure of intracranial volume when using clinical MRI.

Authors:  R N Kaveer Nandigam; Yu-Wei Chen; Mahmut E Gurol; Jonathan Rosand; Steven M Greenberg; Eric E Smith
Journal:  J Neuroimaging       Date:  2007-01       Impact factor: 2.486

6.  Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.

Authors:  M M Breteler; J C van Swieten; M L Bots; D E Grobbee; J J Claus; J H van den Hout; F van Harskamp; H L Tanghe; P T de Jong; J van Gijn
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

7.  Association of Cardiovascular Risk Factors With MRI Indices of Cerebrovascular Structure and Function and White Matter Hyperintensities in Young Adults.

Authors:  Wilby Williamson; Adam J Lewandowski; Nils D Forkert; Ludovica Griffanti; Thomas W Okell; Jill Betts; Henry Boardman; Timo Siepmann; David McKean; Odaro Huckstep; Jane M Francis; Stefan Neubauer; Renzo Phellan; Mark Jenkinson; Aiden Doherty; Helen Dawes; Eleni Frangou; Christina Malamateniou; Charlie Foster; Paul Leeson
Journal:  JAMA       Date:  2018-08-21       Impact factor: 56.272

8.  Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke.

Authors:  E M Arsava; R Rahman; J Rosand; J Lu; E E Smith; N S Rost; A B Singhal; M H Lev; K L Furie; W J Koroshetz; A G Sorensen; H Ay
Journal:  Neurology       Date:  2009-04-21       Impact factor: 9.910

9.  Leukoaraiosis more than dementia is a predictor of stroke recurrence.

Authors:  H Hénon; P Vroylandt; I Durieu; F Pasquier; D Leys
Journal:  Stroke       Date:  2003-11-20       Impact factor: 7.914

10.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

View more
  4 in total

1.  Clinical and MRI features about two types of silent cerebral small-vessel disease in type-2 diabetes mellitus: a retrospective cross-sectional study in a tertiary hospital.

Authors:  Dan-Qiong Wang; Lei Wang; Xiao-Shuang Xia; Miao-Miao Wei; Xiao-Lin Tian; Liang-Fang Wang; Xin Li
Journal:  Quant Imaging Med Surg       Date:  2022-04

2.  Dose-response association between plasma homocysteine and white matter lesions in patients with hypertension: a case-control study.

Authors:  Yujuan Yuan; Xintian Cai; Yan Liu; Nanfang Li
Journal:  Hypertens Res       Date:  2022-08-23       Impact factor: 5.528

3.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

4.  Relationship Between Type 2 Diabetes and White Matter Hyperintensity: A Systematic Review.

Authors:  Dan-Qiong Wang; Lei Wang; Miao-Miao Wei; Xiao-Shuang Xia; Xiao-Lin Tian; Xiao-Hong Cui; Xin Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-21       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.